Andrew Wilner is a professor of neurology at the University of Tennessee Health Science Center, Memphis, and a seasoned neurologist and epilepsy expert who has mastered the less conventional locum career path.
Hospital-based systems-level sepsis interventions in diagnostic testing, antimicrobial stewardship, and program infrastructure can improve outcomes across the continuum of care, according to a new position paper from the Infectious Diseases Society of America (IDSA) and other medical organizations.
Approximately half of children with complicated community-acquired pneumonia (cCAP) receive antibiotics for methicillin-resistant Staphylococcus aureus despite low positivity rates, based on data from a new study presented at the Pediatric Hospital Medicine (PHM) 2026 conference.
Candida auris infections in healthcare settings increased overall between 2022 and 2024, according to data from a new surveillance summary of approximately 40,000 cases published by the CDC.
Immune checkpoint inhibitors (ICIs) have been transformative in the treatment of certain cancers, but as use of the drugs continues to climb, so do the ranks of patients dealing with gastrointestinal (GI) side effects.
Recently, Quincy Harberger, MD, found himself discussing cardiovascular disease with his uncle.
Cases of extensively drug-resistant (XDR) Shigella, for which no approved treatment is available, increased significantly between 2011 and 2023, based on data from approximately 17,000 isolates.
